Furthermore, our data showed that overexpression of CLPP could reduce the levels of cellular and mitochondrial autophagy in cisplatin-resistant cells, increase the ROS levels and apoptosis rates of ovarian cancer cells, and thus improve the drug sensitivity of ovarian cancer cells. The gene discussed is CLPP; the disease is ovarian cancer.